Low-dose rapamycin treatment increases the ability of human regulatory T cells to inhibit transplant arteriosclerosis in vivo. (Q41894403)
Jump to navigation
Jump to search
scientific article published on 14 April 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Low-dose rapamycin treatment increases the ability of human regulatory T cells to inhibit transplant arteriosclerosis in vivo. |
scientific article published on 14 April 2012 |
Statements
Low-dose rapamycin treatment increases the ability of human regulatory T cells to inhibit transplant arteriosclerosis in vivo (English)
S N Nadig
1 reference